SCHEMBL10323504

SCHEMBL10323504

CC(c1ccccc1)N(O)C(=O)c1cccc(N(Cl)C(=O)c2cc3cnc(N4CCC(NC(=O)OC(C)(C)C)CC4)nc3[nH]c2=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 3/20 0.43
▸ DYRK1B Q9Y463 3/20 0.43
▸ CKS1B P61024 1/20 0.39
▸ SKP1 P63208 1/20 0.39
▸ SKP2 Q13309 1/20 0.39
▸ IGF1R P08069 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ MAPK8 P45983 1/20 0.35
▸ KDM4D Q6B0I6 4/20 0.34
▸ CCR5 P51681 1/20 0.34
▸ PARP1 P09874 2/20 0.34
▸ USP30 Q70CQ3 1/20 0.34
▸ BTK Q06187 2/20 0.34
▸ OPRM1 P35372 1/20 0.33
▸ OPRD1 P41143 1/20 0.33
▸ OPRK1 P41145 1/20 0.33
▸ OGFRL1 Q5TC84 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10323992 0.92 DYRK1A (0.46) DYRK1ADYRK1B
SCHEMBL10323484 0.87 DYRK1A (0.51) DYRK1ADYRK1BCKS1BSKP1SKP2
SCHEMBL10323240 0.81 DYRK1A (0.47) DYRK1ADYRK1BCKS1BSKP1SKP2
SCHEMBL10324226 0.75 PTPN11 (0.43) DYRK1ADYRK1BCKS1BSKP1SKP2
SCHEMBL10323483 0.74 DYRK1A (0.70) DYRK1ADYRK1B
SCHEMBL10323316 0.73 DYRK1A (0.68) DYRK1ADYRK1B
Hydrochloric Acid SCHEMBL10322588 0.73 DYRK1A (0.73) DYRK1ADYRK1B
SCHEMBL10323035 0.73 DYRK1A (0.66) DYRK1ADYRK1B
SCHEMBL10447644 0.73 DYRK1A (0.58) DYRK1ADYRK1B
SCHEMBL11304915 0.73 DYRK1A (0.47) DYRK1ADYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184542-A1 PYRIDO PYRIMIDINES ANDERSON KEVIN (US) 2012-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184542-A1 PYRIDO PYRIMIDINES TYMS, TYMP, DPYD DYRK1A 654/4885DYRK1B 570/4885CKS1B 135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback